Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

CLEARMIND MEDICINE, INC

Filed by RK STRATEGIES, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 21, 2026
Income
$10,000.00
Expenses
Not reported
Filing UUID
789f7524-164d-4dbe-bbed-ea55c915526d
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

Psychedelic Legislation H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Literal federal measure citations: H.R. 7091, H.R.2623

ALC · Alcohol and Drug Abuse

H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery (SPEED) Act H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Literal federal measure citations: H.R. 3838, H.R. 7091, H.R.2623

VET · Veterans

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Psychedelics issues

Literal federal measure citations: H.R. 7091, H.R.2623

HCR · Health Issues

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Literal federal measure citations: H.R. 7091, H.R.2623

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.